trial · primary record
NEU-411
Parkinson Disease
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 150 |
| Primary completion | 2028-06 |
| Primary endpoint | Change from baseline in the Roche digital biomarker score using the Roche Parkinson's Disease application (v3.0) compared to placebo |
| Registry ID | NCT06680830 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:44:41.658Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06680830
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.